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ABSTRACT
Title of Thesis: Recirculation Flow Bioreactor for the
Synthesis of Nitroxide and N-Oxide
Pharmaceuticals
Douglas Lischick: Master of Science in Chemical Engineering,
1989
Thesis directed by: Sam S. Sofer, Professor
Sponsored Chair in Biotechnology
An investigation of the properties of calcium alginate
immobilized hog liver microsomes, rich in FAD-containing
mixed function oxidase, was performed. Studies involving
catalyst storage, immobilization of cofactors within the
matrix, and alginate gel concentration were performed using
a 1.8 ml mixed flow micro assay reactor. A recirculation
flow reactor was designed and used for the biochemical
production of 2,2,4,4-tetramethyl-1,3-oxazolidine-1-oxyl, a
potentially useful MRI contrast agent.
The activity of the immobilized microsomes was found
to increase over time when stored in CaCl 2 or in buffer at
4-8 °C. The increase in activity is a result of the removal
of inherent inhibitors present in the microsomal 
preparation. The cofactors NADP + and G6P and coenzyme G6PDH
can be immobilized within the alginate matrix, however
significant losses will result from diffusion of the
cofactors during the catalyst preparation. The rate of
diffusion through the matrix is a function of molecular
weight, NADP + being the largest cofactor is retained the
most. The alginate gel produces a uniform resistance to
mass transfer between 0.5 and 1.5 % gel. The rate of oxygen
consumption is found to be a linear function of the enzyme
concentration. The immobilized enzyme has an effective V max
of 10.4 nmole/min * mg protein.
A recirculation flow reactor was designed for the use
of immobilized microsomes. The nitroxide 2,2,4,4-
tetramethyl-1, 3 -oxazolidine-1-oxyl was produced
enzymatically using 2,2,4,4-tetramethyl-1, 3-oxazolidine as
substrate. The product was compared to the same compound
synthesized organically, using UV/VIS and HPLC. The
formation of the nitroxide free radicals is verified by ESR
spectroscopy.
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CHAPTER I
INTRODUCTION
The liver is sometimes referred to as the
detoxification center of the body. It is within the liver
that the metabolism of many xenobiotics and pharmaceutical
drugs begins [1]. For many of these compounds, the first
step of metabolism is an oxidation process. Once a compound
is oxidized, a hydrolysis step can easily occur resulting in
a more water soluble form of the compound. The water
solubility of the metabolite facilitates the removal of the
compound by excretion through the urinary tract. However,
even without an additional hydrolysis step the oxidized
compounds are inherently more hydrophilic due to an increase
in their dipole moment and polarity.
Aside from hydrogen and carbon, nitrogen is the most
common element found in xenobiotics and pharmaceuticals
[2,3]. The metabolism of many of these nitrogen bearing
compounds begins with the oxidation of the nitrogen atom.
The site for N-oxidation lies within the smooth endoplasmic
reticulum of the liver cells.
The endoplasmic reticulum of hepatic cells are made up
of a network of ribosome-like and smooth membrane, existing
in the form of channels. Viewed under an electron
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microscope they appear as parallel arrays of "rough"
membrane and scattered "smooth" vesicles respectively.
After removing and homogenizing the liver tissue, the
membranes are separable from the bulk tissue through
differential centrifugation. These membranes separated from
the cellular organelles and soluble components are referred
to as "microsomes". The rough and smooth membranes can be
further separated by ultracentrifugation techniques. Once
separated ultrasonication of the microsomes also enables
these elements to be subfractioned even further.
In a procedure developed by Ziegler and Poulsen, FAD-
containing mixed function oxidase (FMO) has been isolated
and purified to homogeneity from pig liver microsomes [4].
FMO has been identified as being the responsible enzyme for
the oxidation of a variety of tertiary, secondary and aryl
amines, some primary amines and a variety of phenothiazine
drugs, in addition to a variety of sulfur containing
compounds [3]. Although present in other tissues such as
the lung and kidney of many mammalian species, the FMO
activity is much greater in the liver and in unusually high
concentrations in hog and human liver [5] . The
monooxygenase is one of the more abundant flavoprotiens of
the liver, accounting for 3-4% of the total liver microsomal
protein from an adult female hog [5].
Although the use of isolated enzymes displays faster
3
reaction rates, isolation and purification of the enzyme is
costly and can lead to deactivation when the enzyme is
removed from its natural environment. The use of microsomes
is a much more feasible approach. Through immobilization,
the flexibility and potential applications of the microsomes
are greatly enhanced. The immobilization of enzymes on or
within a support serves not only the purpose of recovery
from reaction mixtures, but it can also slow enzyme
deactivation by inhibiting protease attack, by reducing
shear in a stirred reactor and by minimizing interfacial
temperature or solvent denaturation [6].
One of the greatest advantages of the immobilization
of FMO is the increase in half-life of the enzyme. Although
this phenomenon is not fully understood it has been reported
by several investigators [7,8]. The half-life of purified
hog liver FMO immobilized on glass beads is extended to
several hours while the half-life of the soluble enzyme is
in the order of 15 minutes [9]. With an extended half-life,
the immobilized enzymes are expected to have higher product
yields. This result has been demonstrated by Camp in his
work using calcium alginate immobilized hog liver microsomes
[ 7 ] -
1.1 APPLICATION
The potential applications of hepatic microsomal
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enzymes are presented in an earlier review [9]. One of the
most promising uses of immobilized enzymes is in their role
as metabolic agents in the transformation of foreign
compounds into useful bioproducts. Enzymes, known for their
specificity in catalyzing unique reactions, can serve as an
indispensable aid to the organic or pharmaceutical chemist.
With the use of enzymes, new compounds, or compounds which
are difficult or thought impossible to synthesize chemically
can be produced biochemically.
The production of metabolites, such as N-oxides or
glucuronides, as new drugs is one illustration of enzyme
utilization. The metabolites of various phenothiazine drugs
have been produced using microsomal enzymes [9]. These
metabolites can also prove useful as drugs themselves. In
fact, the metabolite can have more favorable properties than
the parent compound. For example, a metabolite of
imipramime, imipramine N-oxide, has been reported to have
similar therapeutic effects to the parent compound, however
the side effects, decreased blood pressure and toxicity, are
reduced [10]. Although N-oxides of many pharmaceuticals can
be synthesized via standard practices, some N-oxides are
very difficult to prepare. One such compound is the N-oxide
of the tranquilizer prochlorperazine [9]. In this case, the
enzyme system is ideal.
The microsomal FMO found in hog liver is also known to
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catalyze the production of stable nitroxide free radical
compounds [11]. Nitroxides are paramagnetic organic
molecules containing one unpaired electron in the N-0 group
and are known to stimulate the proton relaxation of the
water environment in which they are dissolved [12]. The
ability of nitroxides to alter the relaxation state of water
makes them useful as Magnetic Resonance (MR) contrast
agents. The utility of stable nitroxide free radicals as MR
imaging enhancers to strengthen the image intensity of
tumors, soft tissue inflammation, and defects in the blood
brain barrier has been demonstrated [13]. They are also
currently being used as probes to monitor biological
membranes and describe the contour of macromolecular
surfaces [14]. Nitroxides have several advantages over
other image enhancement techniques such as altering the
hydration state of tissue and other inorganic paramagnetic
ions. Nitroxides demonstrate many characteristics of
clinically useful NMR contrast enhancers including: 1)
stability at varying pH and temperature, 2) a prolonged
shelf life, 3) chemical flexibility for enhancement of non
specific and of specific systems or processes, and 4)
longer spin relaxation times and lower toxicity than
metallic ions [14,15]. Another advantage is that nitroxides
are readily metabolized and excreted by the kidney [15].
The nitroxide compounds are mainly prepared by
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classical organic synthesis techniques. The procedures
involved are often difficult to carry out without producing
unwanted by-products especially when several oxidation sites
appear on the molecule. This can lead to laborious
separation methods and poor product yield. Once again an
enzymatically catalyzed reaction would prove to be
beneficial.
Another interesting phenomenon of FMO is its product
stereospecificity. The N-oxidation of nicotine by porcine
liver FMO shows stereoselectivity in the formation of its
diastereomeric N-oxide [16]. Reactions involving the (R)-
(+)-Nicotine result in the formation of only trans
1'R, 2'R N-oxide. The result may however be due to steric factors of
the starting material which can effect the attack of the
enzyme [16]. Nonetheless, stereoselectivity is a valuable
asset in chemical synthesis.
1.2 Kinetic Mechanism
The steady state kinetic mechanism which FMO is
believed to follow is an ordered ABC mechanism with an
irreversible step between the AB and ABC enzyme bound
complexes [3]. The order of the substrate addition is NADPH
(Reduced Nicotinamide Adenine Dinucleotide Phosphate), 0 2 ,
and substrate, and the order of product release is the
oxygenated substrate along with water and finally NADP+.
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The steps involved in the FMO catalyzed oxidation of
nucleophilic sulfur or nitrogen containing compounds are
illustrated in Figure I. G6P (D-Glucose-6-Phosphate) and
G6PDH (Glucose-6-Phosphate Dehydrogenase) are used to
regenerate NADP+ back to the usable reduced form as NADPH.
Ziegler and Poulsen [3] have found that NADPH is
capable of reacting with the oxidized form of the enzyme,
however the binding of oxygen or the oxygenatable substrate
to this same form is not detected. Therefore, it was
concluded that NADPH must be the first substrate added.
They have also shown, as well as other investigators [17],
that NADP+ is competitive with NADPH, both binding to the
same form of the enzyme, and noncompetitive with oxygen and
nitrogen bearing substrate. Thus, the first substrate added
is NADPH and the last product to be released is NADP + .
The work of Beaty and Ballou [17] has further
supported this mechanism. They have spectrographically
monitored the appearance and disappearance of a
C(4a)- hydroperoxide intermediate in a stopped flow apparatus.
Analysis of the kinetic mechanism has shown that there is a
reversible connection between the enzyme forms that bind
NADPH and oxygen. In addition they have been able to verify
the order of addition of substrates. According to their
experiments, if the substrate were to bind after NADPH and
before 0 2 , the kinetic formation of the C(4a)-hydroperoxide
8Figure 1.1 Catalytic cycle of FMO. S Stands for a nitrogen
or sulfur containing substrate, and SO, the oxygenated
substrate. The heavy line indicates an irreversible step in
the formation of the C(4a)-hydroperoxide intermediate. The
dashed line shows NADPH oxidation in the absence of
substrate. NADP+ is regenerated by G6P and G6PDH.
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intermediate should be affected by the substrate additions,
yet it was not. Furthermore, if the substrate were to bind
prior to NADPH, the reduction of the enzyme would be
expected to be affected and it was not.
An important step in the mechanism is the formation of
the C(4a)-hydroperoxide flavin intermediate which is a
unique property of this enzyme [18]. It is this form of the
enzyme that is believed to be responsible for the
oxygenation of substrates [18]. The hydroperoxy flavin
binds to the substrate and transfers the oxygen to the
substrate. Within the reaction vessel, the enzyme mainly
takes the form of the intermediate [17]. The oxidation of
amines by this mechanism is an ionic two-electron oxidation
which will yield N-oxygenated products [19]. The oxygen
transfer from the peroxyflavin intermediate is similar to
the oxidation of amines by peroxides. Thus, many compounds
that can be oxidized by organic compounds such as organic
hydrogen peroxide or organic peracids are potential
substrates for the enzyme. However, the ability of the
enzyme to oxidize a compound may be greatly affected by the
geometry and steric factors of the compound [18].
The rate limiting step of the FMO reaction mechanism
is presumed to be either the breakdown of the pseudobase
C(4a)-hydroxyflavin or the release of NADP + [17]. Since
both of these steps occur after the addition of substrates
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and the release of the products, one expects that all
substrates would have the same value of V max . A review of
the literature shows that this is obviously not the case
[20]. The Vmax for lipophilic protonated tertiary amines is
twice that of neutral substrates, however, the Vmax of the
latter can be increased to the former with the addition of a
positive activator such as n-Octylamine (NOA). While this
primary amine is not a substrate, it increases the rate
limiting step to result in a constant value of V max for
virtually all substrates using purified hog liver microsomes
[18]. This suggests that the Vmax found for one substrate
in conjunction with NOA can predict this kinetic constant
for all substrates.
1.3 Endogenous Rate
In the absence of substrate, the FMO oxidase is
capable of oxidizing NADPH to form NADP + and H 2 0 2 in
stoichiometric amounts [3].
NADPH + 02 + H+ -> NADP+ + H2 02
This reaction is referred to as the "endogenous" reaction.
However, the hydroperoxide intermediate reacts much faster
with substrate (N,N-dimethylamine and methimazole) than it
decomposes to give hydrogen peroxide [3]. The endogenous
rate is barely detectable in crude preparations and
progressively increases during isolation and purification.
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This increase in the endogenous oxygen dependent uptake is
an indication of the stability of the C( 4a) -
hydroperoxyflavin intermediate [20]. As the enzyme is
purified it be comes more and more unstable and the
endogenous rate approaches that of the substrate stimulated
rate.
Cavagnaro et al. [2] have performed a detailed
investigation on the endogenous rate. The oxygen uptake of
the enzyme was monitored with and without substrate (N,N-
dimethylamine and Methimazole) at various concentrations of
rat hepatic microsomes. Various plots of the rate of oxygen
uptake of the endogenous reaction versus enzyme
concentration were examined and found to be nonlinear.
However, the total of the endogenous plus the substrate
stimulated rates was linear. The endogenous rate is a
characteristic property of this enzyme and disappears either
completely or partially in the presence of an exogenous
substrate [2]. They were also able to validate this
conclusion mathematically and show that there is no
justification in the subtraction of the endogenous rate from
the substrate stimulated rate.
The endogenous reaction rate of pig liver FMO does
display a significant rate. However, in light of the above
mentioned study and a similar study with pig liver FMO by
Sabourin et al. [20], it can be concluded that at or near
12
enzyme saturation conditions of substrate the NADPH
oxidation is due entirely to the oxidation of substrate.
1.4 Enzyme Activity
There are many factors about the animal from which the
microsomes are obtained that have both positive and negative
affects on the activity of FMO in the liver tissue.
Individual variations of up to 2-fold in specific activity
are not uncommon among adult hogs [5]. The major factors
are: sex, physical size and health, breed and time of last
feeding before slaughter [4,5].
Other factors affecting the activity arise during the
microsomal and catalyst preparations. FMO is highly
susceptible to postmortem inactivation. The liver should be
removed and cooled to 4 °C within 10 minutes to prevent
significant losses in activity [5]. FMO is also known to be
very temperature and pH sensitive and should be handled
under carefully controlled conditions.
1.5 Cytocrome P-450 Monooxygenase
The cytocrome P-450 dependent monooxygenase system, as
well as FMO, must be taken into consideration when
discussing the metabolic oxidation of a broad range of
chemicals, drugs and pesticides. Earlier, the
characterization of FMO the NADPH-dependent oxidation of
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compounds was attributed to the cytocrome P-450 system [20].
It is now apparent that many nitrogen and sulfur containing
compounds are oxidized by FMO. The cytocrome P-450
dependent monooxygenase system and its genetic control have
extensively been studied and characterized in mice [20].
The metabolic pathway of the compounds may depend upon the
relative amounts and the relative affinity for substrate of
the two enzyme systems. However, the oxidation pathway by
FMO and by cytocrome P-450 are different and may lead to
different end products [19]. Oxidative N-dealkylation is
catalyzed almost exclusively by cytocrome P-450 while N-
oxidation is carried out by both systems [21]. However, N-
oxidations catalyzed by cytocrome P-450 generate
intermediate radicals and is restricted to a few substrates
while N-oxidation by FMO follows an ionic mechanism without
the formation of intermediate radicals [19].
Although purified FMO is very well understood,
immobilization of hepatic microsomes raises new questions.
With the immobilization of hog liver microsomes within a
calcium alginate matrix an increase in the half life is
observed [7], also an increase in the activity is seen over
time [22]. The reasons for the changes in stability and
activity are thought to be the result of a loss of inherent
endogenous inhibitors or a physical realignment of the
14
enzyme during the immobilization process. However this
phenomena still remains uncertain.
A second question which arises is the possibility of
immobilizing the cofactors, G6P, G6PDH and NADP + , within the
matrix. Having the cofactors entrapped within the matrix
may present several advantages over having the cofactors
introduced in the reaction medium. Since the enzyme is held
within the bead, the reaction takes place within the bead.
If the cofactors are immobilized within the matrix they will
not have to overcome the internal as well as external mass
transfer resistance, thus reducing the requirement of a
sufficient concentration gradient to force the cofactors
inside the beads. This will also ease the separation of the
final product from the cofactors.
These are the main areas of interest, as well as the
investigation of operational parameters which are important
in the development of a practical reactor design for the
production of small quantities of pharmaceutical compounds
using immobilized microsomes.
CHAPTER II
OBJECTIVE
The primary objective of this study has been to
develop a recirculation flow bioreactor for the enzymatic
synthesis of pharmaceuticals using immobilized hepatic
microsomes.
The first step has been the investigation of the
immobilized enzyme catalyst. The change in activity over
time, when stored in CaCl2 or in buffer, has been examined.
A spectral analysis, a protein balance, and an analysis of
the weight loss of the catalyst have been performed over
time to detect losses of inhibitors from the immobilized
matrix. The benefits of immobilizing cofactors within the
matrix have been evaluated. Other operational parameters
including enzyme loading and cofactor and substrate
requirements have also been defined.
A recirculation flow reactor has been designed and
used for the biochemical synthesis of
2,2,4,4-tetramethyl 1,3-oxazolidine-3-oxyl by the immobilized enzyme. The
bioproduct has been compared to the same product synthesized
chemically.
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CHAPTER III
MATERIALS AND EXPERIMENTAL METHODS
Alginic acid, Tris buffer, cofactors NADP + and G6P, coenzyme
G6PD and protein assay kit are obtained from Sigma Chemical
Company, St. Louis, Missouri. 2-Amino-2-methyl-1-propanol,
para-toluensulfonic acid, sodium sulfate anhydrous, sodium
bicarbonate and 3-chloroperbenzoic acid were obtained from
Fluka Chemical Corp. Ronkonkoma, New York. Chlorpromazine
was obtained from Smith, Kline and French Laboratories. The
hog liver microsomal preparation was a gift from Dr. D.M.
Ziegler of the University of Texas. Acetone, benzene,
ethylene dichloride and methylene chloride are of a suitable
reagent grade.
3.1 Immobilized Enzyme Catalyst Preparation
Sodium alginate gel is made by adding 1.87 grams of
NaCl and 100 ml of 0.01M Tris buffer, pH 7.4 at 37 °C, in a
250 ml beaker. While stirring the solution over a low heat
slowly add 2.00 grams of alginic acid. Once the alginic
acid is added, the mixture becomes thick and a glass
stirring rod is used to help the mixing process. This
mixture is autoclaved and stored at 4-8°C.
The immobilized enzyme catalyst is prepared by mixing
16
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equal volumes of the chilled sodium aglinate gel and the
cold, prepared liver microsome mixture in a 20 ml vial. The
mixture is stirred on ice with a glass rod to a homogeneous
state. The mixture is then extruded through a 21 gauge
syringe needle using a syringe pump set at a flow rate of
0.4 ml per min. The extruded material falls drop wise into
an ice cold and gently stirred 0.1M CaCl 2 solution. When
the drop hits the CaCl 2 an ionic replacement takes place
between the sodium in the gel and the calcium in the
solution to form a stable calcium-alginate matrix which
entraps the enzyme. The mixture will produce on average 50
drops or "beads" per ml.
The beads are left to cure in the CaCl 2 solution for
10 hours at a temperature of 4-8 °C. After the 10 hours of
curing time, the CaCl 2 is drained off and the beads are
washed and stored in 0.01M Tris-buffer, pH 7.4 at 37 °C. The
beads remain in the buffer 4 hours before using.
3.2 Protein Determination
The amount of protein contained in solution and in
beads was determine using a protein assay kit based on
Peterson's modification of the micro-Lowry method which uses
sodium dodecylsulfate to facilitate the dissolution of
relatively insoluble lipoproteins.
One bead is placed in a test tube and crushed with a
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glass rod and diluted to 1 ml, the sample is then measured
for protein content per bead. Similarly 1 ml of a solution
is measured. A minimum of three trials are done and the
results averaged.
3.3 Micro Assay Technique
The reaction vessel consists of a stirred 1.8 ml
jacketed reactor, maintained at a temperature of 37 0C by a
constant temperature bath. The activity of the enzyme is
determined by monitoring substrate dependent oxygen
consumption. The oxygen consumption is measured
polarographicaly using a YSI 4004 Clark oxygen probe
inserted in the vessel. The signal from the probe is sent
to a strip chart recorder through a signal conditioner. The
reactor setup is shown in Figure 3.1.
Prior to all assays, the vessel is rinsed several
times with methanol, distilled water and buffer. The vessel
is then filled with 1.65 ml of buffer and saturated with air
(228 nmole/ml). Once saturation is complete the catalyst is
added in the form of beads or as free organelles. The
cofactors are added in two injections of 25 ul each of stock
solutions of NADP+ and G6P/G6PDH such that the vessel
contains 3.0 mM NADP+ , 3.0 mM G6P and not less than 2
units/ml G6PDH. Within 30 seconds the endogenous oxygen
consumption of NADPH will appear. After approximately
OXYGEN
PROBE
WATER IN
SIGNAL
CONDITIONER
MAGNETIC
STIRRER
GROUND GLASS
JOINT
WATER OUT
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CHART RECORDER
Figure 3.1 Micro Assay Reactor Setup.
20
2 minutes, the substrate is injected and a second change in
slope appears, indicating substrate dependent oxygen
consumption.
3.4 Verification of the Major Oxidative Product
Although FMO catalyzes the NADP + dependent oxidation
of a variety of different compounds, activity is
conveniently measured by following methimazole (MMI)
dependent oxygen uptake polarographically [5]. It is shown
that the oxidation of MMI is catalyzed exclusively by FMO
from liver microsomes [24].
To verify that MMI is the major substrate, not the
endogenous reaction, several control runs were performed.
Using free enzymes in the micro assay reactor, at a 1 mM MMI
concentration, the reaction was allowed to consume about 75%
of the oxygen in the reactor after air saturation. This
corresponds to roughly 325 nmoles of 0 2 consumed. At this
point an excess of catalase was added to the reaction
mixture. Catalase breaks down H 2 0 2 according to the
following reaction;
Catalase
After adding the catalase the amount of dissolved oxygen
increased less than 10 nmoles.
The increase in oxygen most likely comes from the
dissolved oxygen in the catalase solution, or it may come
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from the breakdown of H 2 0 2 resulting from the endogenous
reaction during the time between substrate additions. In
either case it can be concluded that the oxygen consumption
rate is indicative of the substrate oxidation rate.
3.5 Bead Storage
In order to investigate the phenomena of the increase
in rate during the storage period, the possibility of
proteolytic species acting as inhibitors leaching out of the
matrix was investigated. Under a constant ratio of 1 bead
per ml storage medium a protein balance on the storage
medium gain and bead loss was examined, a UV/VIS
spectrographic analysis on the storage medium was done and
the weight loss of the beads was monitored over time.
3.6 Immobilization of Cofactors
Immobilizing the cofactors along with the microsomes
poses a problem. During the bead making process the beads
remain in CaCl 2 for 10 hours and in buffer for a minimum of
4 hours. If the cofactors are immobilized they will diffuse
out of the beads during this time. Being that they do
diffuse out, it may be possible to make the beads in a
solution containing the cofactor and allow them to diffuse
into the bead while they are curing.
A comparison based on the total weight of cofactor
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used was made in order to compare the results of
immobilizing the cofactors in the bead with the results of
injecting the cofactors into the reaction medium. The
quantity of cofactors injected into the reactor using 10
beads was multiplied by 5 and immobilized in 1 ml of
gel/microsomal homogenate (approximately 50 beads) and
extruded into 50 ml of calcium chloride and transferred to
50 ml of buffer. A second batch of 50 beads were extruded
into 50 ml of calcium chloride containing the same quantity
of coefactors immobilized. A third batch of 50 beads were
extruded and stored in 50 ml of buffer containing the same
amount of cofactor. A fourth batch was prepared in the
standard way maintaining a ratio of 1 bead to 1 ml of curing
and storage medium. A total of three sets of the four above
mentioned combinations were performed for NADP + , G6P/G6PDH
and all together NADP+/G6P/G6PDH. The micro assay were
carried out in the usual manor where the cofactor(s) not
immobilized were injected.
Control runs were done using microsomal beads without
adding the cofactors and using blank alginate beads adding
the cofactors. The microsomal beads do show a small but
negligible endogenous rate, while the blank beads did not
result in any significant rate.
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3.7 Organic Synthesis
The starting material used in the recirculation
reactor experiments of the latter section and its nitroxide
are not readily available and were chemically synthesized.
3.7 (i) Synthesis of 2,2,4,4-tetramethyl-1,3-oxazolidine
The starting material, 2,2,4,4-tetramethyl-1,3-
oxazolidine (TOX) was produced according to methods outlined
by Bordor et al. [25]. 23.7 Grams of
2-amino-2-methyl-l-propanol and an equimolar amount of acetone were added to a
round bottom flask with 50 mg ground para-toluenesulfonic
acid in 75 ml of dried benzene. The reaction mixture was
stirred and heated to a gentle boil, 110 °C, to maintain a
steady reflux. As the reaction proceeds water will be
produced in a 1:1 ratio with 2,2,4,4-tetramethyl-1,3-
oxazolidine. The water product of the reaction was
separated using a Dean Stark Separator. The reaction was
allowed to continue for 22 hours, at which time the
theoretical amount of water was produced. The water was
discarded and the solvent was evaporated in a rotary film
evaporator under vacuum. The remaining clear yellow liquid,
approximately 40 ml, was further purified by distillation.
A series of two distillation processes were performed
at atmospheric conditions. The first was a simple
distillation where 50% of the liquid was collected as
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overhead vapor within a range of 120-135 °C. The condensed
vapor, a clear liquid, is distilled a second time using a
packed column. Three fractions were collected; I < 128°C
4.95 grams, II 130-133 °C 7.25 grams, and III 137-139 ° C
5.28 grams.
The product, 2,2,4,4-tetramethyl-1,3-oxazolidine, was
identified using Proton NMR. The NMR spectra of each
fraction shows chemical shifts occurring at 3.8(S 2H, -CH 2 -
0-), 1.9(B 1H -NH), 1.4(S 6H -CH 3 ) and 1.3(S 6H -CH 3 ) which
is in agreement with published values [26]. An additional
peak occurs at a chemical shift of 7.8, aromatic hydrogen,
indicating that these fractions contain a small amount of
benzene (fraction I > II > III). The NMR spectrum of
fraction III is shown in Figure 3.2. Fraction II will be
used for further organic synthesis and fraction III will be
used for biochemical synthesis.
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3.7 (ii) Synthesis of 2,2,4,4-tetramethyl-1,3-oxazolidine
Nitroxide
The synthesis of 2,2,4,4-tetramethyl-1,3-oxazolidine -
1-oxyl was carried out under mild conditions to prevent
undesired side reactions. To a reaction medium of 125 ml of
methylene chloride 2.6 grams of starting material, 2,2,4,4-
tetramethyl-1, 3-oxazolidine at 0-5 0C, 6.6 grams of
3-chloroperbenzoic acid dissolved in methylene chloride was
added drop wise to the well-stirred mixture. After adding
the 3-chloroperbenzoic the mixture took on a clear yellow-
green color. The temperature was allowed to rise to room
temperature after 1 hr. and left to stir for 24 hours.
Once the reaction was completed, the mixture was
washed with 0.025 moles NaOH to remove the acid produced.
Anhydrous sodium sulfate was added to remove water and the
methylene chloride was removed using a rotary evaporator.
4.33 Grams of a green paste remained and was brought up with
40 ml of hexane and stirred for 1 hour. The green color
residue was transferred to the hexane and a white solid
remained. The liquid was allowed to evaporate resulting in
1.62 grams of a green oily residue.
The green residue was further separated and purified
using a chromatographic reparatory column containing 40
grams of 70-230 mesh silica gel. The residue was brought up
in a 2:1 hexane/ethyl acetate solvent and eluted with the
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same solvent system. Two distinct bands resulted. First a
blue band and second a yellow band. The eluant was
collected in eight separate flask over time. Thin plate
chromatography using the same hexane/ethyl acetate solvent
system was done on each of the fractions collected for
product identification, refer to Table 1. The solvent was
again evaporated off and the fractions combined according to
the TLC results. Table 2 shows the results of ESR
spectroscopy.
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Table 1. COLUMN CHROMATOGRAPHY RESULTS OF ORGANIC SYNTHESIS
TLC Rf
Fraction 	 Color 	 Volume 	 0.8 	 0.6 	 0.5 	 0.4
1 	 Before Blue
	 20 ml 	 +
2 	 Blue 	 25 	 + 	 +/-
3 	 Blue/Yellow
	 10 	 + 	 +
4 	 Yellow 	 20 	 +
5 	 Yellow/Clear
	 25 	 + 	 +/-
6 	 Clear 	 30 	 +
7 	 Clear/Cloudy 	 20 	 +
8 	 Cloudy 	 20 	 +
After Combining and Drying
Fraction 	 Color
	 Weight
	
1,2 	 Yellow oil 	 0.14g
	
4,5 	 Yellow crystals	 0.24g
6,7,8 	 Orange oil 	 0.35g
3 	 Yellow oil 	 0.06g
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Table 2. RESULTS OF ESR SPECTROSCOPY OF NITROXIDE PRODUCTS
Sample 	 Peak Area Gain Peak Area/Gain
	
AN 	 Conc.(Gauss) 	 (mM)
Frac 1,2 	 26.0 	 8x103 	 3.25x10-3 	 14.5 	 0.18
Frac 4,5 	 7.6
	 4x102 	 1.84x10-2 	 14.5 	 1.08
Frac 6,7,8 11.6
	 10x102 	 1.16x10-2 	 14.5 	 0.65
Concentrations were determined by makeing 1 mM samples and
comparing them to a standard. A linear relationship between
peak area/gain and concentration was assumed. Benzene was
used as solvent.
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3.8 Bioproduct Analysis
After a reaction has been completed both the beads and
the reaction medium are collected and extracted using
ethylene dichloride. Prior to the extraction the pH of the
medium is raised to 10 with sodium bicarbonate to bring the
oxidized product into the organic phase. The organic
solvent is evaporated and the resulting weight noted.
(a) The product of Chlorpromazine is determined by TLC.
Elution is done on silica gel plates developed in a 7:1:2
Acetone/Water/6 M Ammonia solvent. The product and starting
material have Rf 0.2 and 0.8 respectively.
(b) The product of 2,2,4,4-tetramethyl-1,3-oxazolidine-
3-oxyl is identified by EPR Spectroscopy.
3.9 Instrumentation
Varian E-12 EPR Spectrometer.
Perkin-Elmer Series 10 HPLC with a LC 135 Diode Array
Detector with a 50:50 hexane/ethyl acetate mobile
phase and a CRI C8 column.
Perkin-Elmer Lambda 3B UV/VIS Spectrometer.
CHAPTER IV
RESULTS AND DISCUSSION
4.1 Increase in Rate During Storage Time
Plots of the oxygen consumption rate versus storage
time in calcium chloride and in buffer are shown in Figures
4.1 and 4.2. Although there is some degree of scatter among
the data, both curves indicate an increase in rate. Storage
in calcium chloride displays a steady increase while storage
in buffer increases in stages. The rate, when stored in
buffer, increases rapidly and reaches a plateau after
approximately 4 hours and increases again after 50 hours.
The initial increase in rate during the first 4 hours
after the beads are transferred to buffer is most likely a
result of the decrease in mass transfer resistance due to
softening of the beads when removed from calcium chloride.
However, the second increase can not be explained in the same
manner. This may be the diffusion of endogenous inhibitors
from the matrix or the contamination or growth of another
microorganism. Contamination is unlikely because of
controlled storage conditions and sterilization. The
microsomal mixture in not purified and can contain many
endogenous compounds, some of which are inhibitors [5]. The
stages may be a division of species of different molecular
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weights moving into the liquid medium. When the beads are in
the calcium chloride the ionic linkage between alginate and
calcium is at its greatest, maintaining a smaller pore size
and stronger beads, slowing the diffusion of the inhibitors.
This is believed to be the reason for the absence of visual
stages when stored in calcium chloride.
It should be noted that repeated freezing and thawing
can be used as a method of purifying the enzyme by breaking
the vesicles allowing inhibitors to escape [4]. This type of
purification may be taking place during storage at a
temperature near 0 °C. Also, as the enzyme becomes purified an
increase in activity is observed [23].
In order to identify the diffusion of protein from the
beads to the storage medium, a spectral analysis, a protein
balance on the beads and medium, and an analysis of the
weight loss of the beads were performed. There is positive
evidence of mass diffusion out of the beads shown by the
weight loss of the beads over time, see Table 2. The
spectral analysis, Figure 4.3, and the results of the protein
balance, Table 3, indicate that protein is obviously
diffusing into the storage medium and that UV/VIS spectrum of
the protein is similar to that of the microsomal preparation.
The nature of the inhibitors can not be determined by these
tests. Ziegler [18] suggests that some forms of lipids can
act as inhibitors. A diagnostic test for lipids would help
to better identify the nature of the inhibitors.
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Figure 4.1
	 The Effect of Storage Time
in CaCl 2 on Activity
Storage Time (hours)
Initial rates are plotted using 1mM MM1 as substrate. The reaction
rate steadily increases over time.
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Figure 4.2 Effect of Storage Time
in TRIS Buffer on Activity
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Initial rates are plotted using 1 mM MMI as substrate. The reaction rate
increases to a plateau after 4 hours and increases again at 50 hours.
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Table 3. WEIGHT LOSS OF BEADS DURING STORAGE TIME
Dry Weight of 10 Beads (mg)
Time (hr.) 	 T-1 	 T-2 	 T-3 	 Average
CaCl 2
0 	 15.1 	 13.9 	 14.4 	 14.5
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Buffer
	
0 	 (10) 	 14.0
	
10 	 (20) 	 9.5
	
25 	 (35) 	 8.4
	
50 	 (60) 	 7.7
	
75 	 (85) 	 7.8
	
100 	 (110) 	 8.1
The numbers in parenthesis represent total storage time, in
CaCl 2 plus buffer.
Figure 4.3 UV/VIS Spectrum of the Storage Medium
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Table 4. PROTEIN BALANCE OF BEADS AND STORAGE MEDIUM DURING
STORAGE TIME
Micrograms of Protein per Bead or per ml *
Time 	 Total
(hr.) 	 Protein
Gel/Microsome
Homogenate 	 (Drops)
0 	 303 	 303
CaCl 2
	(Liquid)	 (Beads)
10 	 27.3 	 276 	 303
	
/ 	 \
Buffer 	 (Liquid) (Beads)
20 	 30 	 242 	 299
35 	 35.8 	 239 	 302
85 	 45.7 	 241 	 313
110 	 47.5 	 232 	 306
The above values represent an average of 3 trials. The
initial protein content of both CaC1 2 and buffer is 0.
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4.2 Cofactor Immobilization
Figures 4.4, 4.5 and 4.6 show that there is a
significant decrease in the rate of all cases of
immobilization when compared to the standard method of
introducing the cofactors. However, it is evident that a
portion of the cofactors remain or diffuse into the beads
when compared to pure calcium alginate beads. An interesting
point is that in both cases when NADP + is immobilized within
the matrix the reaction rate is approximately 45% of the
standard procedure. In the experiment when only G6P/G6PDH is
studied, the run where the cofactors are put in the buffer
was the nearest to that of the standard procedure. This
shows that NADP+ is less mobile than G6P and G6PDH. G6P and
G6PDH appear to be able to move in and out quite freely and
no advantage is gained by their immobilization while NADP + is
retained.
In this case the use of a macromolecular form of NADP +
may be better suited for immobilization. A larger molecule
will be more likely to be retained. If this can be
immobilized and retained in the beads, the beads could be
reused several times without additional NADP + requirement or
separation.
In an effort to increase the amount of NADP + retained
an investigation of different support matrixes may be
beneficial. Examples of other potential supports would be
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polyvinyl or polyamide gels. Here the attempt is to create a
pore size large enough for substrate to enter but small
enough to retain the cofactors. With this in mind, other
methods such a polymer coating around the beads or a membrane
enclosed system would also present possible avenues of
investigation.
Figure 4.4 Immobilization of NADP +
Percent Oxygen Consumption
1 mm MMI is used as substrate.
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Figure 4.5 Immobiliztion of G6P and G6PDH
Percent Oxygen Consumption
1 mm MM( is used as substrate.
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Figure 4.6 Immobilization of C6P, G6PDH
and NADP +
Percent Oxygen Consumption
1 mm MMI is used as substrate.
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4.3 Enzyme loading
Figure 4.7 shows the effect of alginate gel on the
reaction rate. Within the range studied, 0.5-1.5 % alginate,
it appears that the alginate gel has little or no effect on
the oxidation rate. The various alginate gel concentrations
were produced by changing the ratio of gel to microsomes
during the catalyst preparation. A study by Lakwala [27]
using activated sludge immobilized in calcium alginate,
showed the effect of calcium chloride concentration used to
cure the beads also has little or no effect on the rate.
Apparently, the alginate matrix produces consistent and
uniform resistance to mass transfer (pore size) under these
conditions.
An important consideration of the gel concentration is
the bead stability. In the micro assay reactor, the beads
are subjected to continuous pounding by the stirring
mechanism. This drastically affects the physical integrity
of the beads. At alginate concentrations below 0.5% beads do
not form when the homogenate is extruded into the calcium
chloride. At a gel concentration of 1% the beads will resist
breaking for about 1 hour while at 1.5% they will last longer
than 4 hours in the micro assay reactor.
In light of the above mentioned study the same data can
be plotted as oxidation rate versus protein concentration,
Figure 4.8. This plot indicates that the reaction rate
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increases proportionally with an increase in protein. The
highest possible enzyme loading is of course the most
desirable condition. If the loading is too low the reaction
will proceed at a very slow rate and if the loading is too
high the beads will not form. A 1% gel concentration
produces beads containing approximately 250 mg each. This
number will vary depending on the protein concentration
(enzyme purity) of the microsomal mixture used.
Figure 4.7 Effect of Alginate Gel Concentration
on Acitivity
4°5
96 Alginate Gel Concentration
The reaction rate is uneffected by the alginate gel concentration.
Figure 4.8 Effect of Enzyme Loading
on Activity
Protein Concentration (ug/bead)
Within this region, the reaction rate increases linearly with
respect to enzyme concentration. Beyond 350 mg/Bead, beads
do not form in CaCL2.
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4.4 NADP+ Saturation Requirement
The requirement of NADP + for free and calcium alginate
immobilized microsomes was investigated. Free microsomes
saturate at 3 mM while immobilized microsomes saturate at 5
mM, Figure 4.9. The sigmoidal appearance of the saturation
curve suggests a "complex" or "abnormal" kinetics with
respect to NADPH (NADP + is converted to NADPH by the
regeneration system at a much higher rate than NADPH is
consumed). This may be a result of using the oxygen
consumption rate as an indication of the NADPH consumption,
even though there is a 1:1 stoichiometric relationship
between NADPH and oxygen. One other point of interest is
that the curve does not appear to pass through the origin.
The presence of endogenous substrate is the probable cause
[4].
The catalytic function of enzymes may be affected and
controlled by the interaction with ligands not only at or
near the active site but also at allosteric sites. Such
enzymes are labeled allosteric enzymes and do present
"complex" kinetics. Allosteric enzymes are generally
oligomers with several identical subunits and play an
important role in metabolism. Allosteric effecters, usually
structurally unrelated to substrate may be bound to the
enzyme at an allosteric site, thus changing the catalytic
activity. In many cases allosteric properties are lost as
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the enzyme is purified and will begin to exhibit Michaelis-
Menten kinetics.
The higher saturation requirement of the immobilized
microsomes is due to the mass transfer resistance of the
matrix. The lower velocity is the result of the additional
resistance becoming the rate limiting factor. It is possible
to overcome the external limitation in a recirculation flow
apparatus. Chien and Sofer [27] have demonstrated this using
calcium alginate immobilized yeast cells in recirculation
mode. They showed that the rate of ethanol production could
be increased from 0.175 g ethanol/hour to 0.34 g ethanol/hour
by increasing the flow rate.
4.5 Methimazole and n-Octylamine Saturation Requirements
The saturation curve of MMI, Figure 4.10, is found to
be 0.3 mM and indicates substrate inhibition. At the
saturation concentration of MMI several runs were made to
find the saturation of n-octylamine (NOA), Figure 4.11. From
the standpoint of the argument presented earlier regarding
the rate limiting step of the catalytic cycle, the apparent
Vmax for the immobilized enzyme can be found. Assuming
Michaelis-Menten kinetics, a reciprocal plot gives a value of
Vmax = 10.4 nmoles/min * mg protein.
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Figure 4.9 NADP+ Saturation Requirement
Free Microsomes
Immobilized
Microsomes
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NADP+ Concentration (mM)
Free microsomes (3.5 mg total) saturate at 3 mM NADP + while
immobilized microsomes (3.2 mg total) saturate at 5 mM NADP + .
The matrix has a strong effect on the saturation concentration.
Figure 4.10 Methimazole Saturation
Requirement
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MM1 saturates the immobilized enzyme at a concentration of 0.3 mM.
At higher concentrations substrate inhibition is observed.
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Figure 4.11
	 n—Octylamine Saturation
Requirement
NOA Concentration (mM)
At substrate saturated conditions (0.3 mM MMI), NOA saturation
occurs at 10 mM. A Lineweaver—Burke plot results in a 	 of
10.4 nmole/min * mg protein.
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CHAPTER V
RECIRCULATION REACTOR
The micro assay reactor is a useful tool for
preliminary studies involving kinetic studies on immobilized
organisms but it is limited in its practical application. A
recirculation flow configuration rather than a mixed flow
reactor is a more suitable setup for practical applications
as well as a tool for obtaining inherent reactor design
parameters for immobilized microorganisms.
The presence of external diffusional gradients of the
immobilized biocatalyst will distort the kinetic reaction and
often result in misleading kinetic parameters such as V max
and Km . In a mixed flow configuration such gradients often
exist at low agitation speeds. Higher agitation speeds will
lead to deactivation and often the destruction of the
biocatalyst due to the continuous pounding of the stirring
mechanism. In a packed bed bioreactor immobilized bacterial
alginate beads have been in continuous operation for several
months in the NJIT Biotechnology Lab while even the strongest
beads will only last a few hours in a mixed flow apparatus.
The design scheme of the recirculation bioreactor is
shown in figure 5.1. The reaction medium is circulated
between a temperature controlled reservoir and a packed bed
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Figure 5.1. Recirculation Flow Reactor.
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reactor using a peristaltic pump. A Clark-type impingement
dissolved oxygen probe is used to monitor the oxygen level of
the reservoir. Oxygen is supplied to the system by sparging
either pure oxygen or a mixture of oxygen and nitrogen to
achieve a desired oxygen level.
A similar recirculation configuration has been used by
Ford et al. [²9] for the kinetic studies of glass immobilized
Tryspin used to catalyze the hydrolysis of BAPA (N-benzoyl-
DL-arginine-P-nitroanilide) and ALME (N -acetyl-L-lysine
methyl ester). Instead of monitoring the oxygen consumption
of oxygen the disappearance of substrate is measured using a
UV/VIS in line spectrometer. This configuration is designed
to determine an operating regime with respect to flow rate to
minimize mass transfer resistance. In a low-flow regime the
substrate concentration at the surface of the bead is lower
than the bulk medium. With increased flow rate it is
possible to eliminate the external film resistance to mass
transfer. This phenomena has also been demonstrated for
alginate immobilized yeast using a recirculation reactor
[²7].
The design of the bioreactor was based on the design
parameters from Chien and Sofer [²7] and other experiments
performed in the NJIT Biotechnology Lab using immobilized
bacteria. The reactor was sized to provide 7.58 ml/min * cm ²
at a flow rate of 40 ml/min (100 ml/min maximum of pump).
55
The packing height was determined to be 1 cm through
experiment. Values larger than 1 cm will cause too great a
pressure drop and force the beads through the packing
supports at high flow rates. Based on a packing factor of
1.3 for spheres and a bead volume of 0.018 ml (55 beads/ml)
each stage could hold up to 120 beads. This value was kept
at 100 to allow for the swelling of the beads over time.
The liquid is pumped in through a distributor at the
bottom of the column to prevent channeling and damage to the
beads by the feed stream. The column was designed to have
variable sizes allowing for 1 to 5 stages. A maximum of 500
beads or 125 mg of protein (250 ug/bead) can be used.
In the recirculation mode the number of large scale
runs was limited by the high cost of cofactors.
Chlorpromazine (CPZ) was used as the substrate to test
the performance of the recirculation flow reactor, under pure
oxygen saturation conditions (1085 nmole/ml) at 37 °C and pH
7.4. A scale up of 15 times that of the micro assay reactor
was run.
Upon the addition of CPZ, substrate dependent oxidation
was observed by a change in rate from 14.5 nmoles/min to ²4
nmoles/min. The initial concentration of CPZ in the reaction
medium was 0.3 mM. Figure 5.² shows the progress of the run
over a 5 hr period. TLC was used to verify the final product.
During this run it was noted that the rate of oxygen
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removal by diffusion is significant above air saturated
conditions, thus distorting oxygen consumption measurements.
For this reason air saturation was used in the proceeding
experiments even though higher levels of oxygen may yield
higher reaction rates.
The recirculation reactor was next used for the N-
oxidation of TOX, at a scale up ratio of 15 times the micro
assay reactor. Prior to this run the saturation
concentration of TOX was determined in the micro assay
reactor. Although at higher concentrations the initial rate
is higher, the total product yield at lower concentrations is
higher, see figure 5.3. If one looks at a time period beyond
²0 minutes the optimum concentration is 11 mM. The pH may be
influencing the reaction at high concentrations of TOX.
Oxygen consumption measurements as well as HPLC, figure
5.4 were used to follow the reaction. After the addition of
substrate there was no noted increase in the oxygen
consumption. At this point sample #1 was taken. After 3
minutes a sudden drop in the oxygen level was observed (13
nmole/ml) and sample #² was taken. A large peak was formed,
this peak is believed to be an intermediate. As time
progressed with no change in the consumption rate an
additional injection of TOX was made, shortly after which a
small drop the oxygen level was noted (3 nmole/ml) and sample
#3 was taken. In comparison of sample #² with #3, it appears
Figure 5.2 CPZ N—Oxidation in the
Recirculation Flow Reactor
Reaction Time (hours)
Reaction was run under oxygen saturated condition at an initial
concentration of 0.3 mM CPZ. Rates were measured at 60% oxygen
saturation.
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Figure 5.3 Rate vs. TOX Concentration
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Reaction Time (min)
The numbers at the end of each curve indicate the amount of
TOX injected (1 ul = 6.6 umoles). Saturation occurs at a concentration
11 mM in the reactor.
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Figure 5.4 Biochemical N-oxidation of TOX followed by H?LC
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that the intermediate is decreasing and the final product is
appearing. A third injection of TOX was made but the oxygen
level remained constant. A fourth sample shows a further
decrease in the hydroperoxy intermediate and an increase in
the final product. A repeat of this run was made,
unfortunately without favorable results.
Isolation of the intermediate peak would be very
helpful in identifying the nature of the intermediate. The
isolation could also lead to the development of a new and
versatile oxidizing agent. However such a task is beyond the
scope of this work.
The final test for the end product is identification by
ESR. This is a clear test for the presence of a stable free
radical. A value of 15 Gauss for AN is indicative of a
nitroxide. The bioproduct disolved in benzene results in an
AN = 15.5 Gauss.
A comparison of the bioproduct with the synthetic
product is made using UV/VIS spectroscopy, HPLC and ESR shown
figures 5.5, 5.6 and 5.7 respectively. Both the bioproduct
and the synthetic product appear to be the same.
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Figure 5.5 UV/VIS Comparison of bioproduct and organic product
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Figure 5.6 HPLC Comparison of bioproduct and organic product
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Figure 5.7 ESR Comparison of bioproduct and organic product
CHAPTER VI
CONCLUSIONS AND RECOMMENDATIONS
The study has shown that the oxygen consumption rate of
immobilized microsomes increases over time due to the removal
of inhibitory species. Storage in buffer or CaCl 2 acts as a
purification process by allowing endogenous inhibitors to be
removed from the microsomes. By washing the beads several
time with fresh buffer, it may be possible to accelerate this
process. A very convincing study would be to see the
influence of the inhibitors on the activity of the soluble
enzyme by reintroducing them in the reaction medium.
The cofactors NADP + , G6P and coenzyme G6PDH can be
immobilized with the microsomes in the alginate gel, yet
there is a significant loss in the effectiveness when
compared, on a weight basis, to introducing them through the
reaction medium. The cofactors will diffuse out of the beads
during the curing and storage time. The use of a
macromolecular form of NADP + should be investigated for
improved retention within the bead. Also, the possibility of
other support matrices should be investigate, as well as
other methods of entrapment, for a minimization of the
cofactor requirement.
Alginate gel provides a uniform pore size at various
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concentrations. The resistance to mass transfer by the matrix
is constant over a range of 0.5-1.5 % alginate gel. The
oxygen consumption rate increases linearly with enzyme
loading (protein concentration). The microsomal beads will
retain physical integrity at gel concentrations below 1 %.
After curing the beads in CaCl 2 and transferring them to
buffer, a constant rate (resistance to mass transfer) is
obtained after 4 hours and is maintained up to 50 hours.
The recirculation flow reactor is a practical method of
producing large scale runs for longer time periods. However,
process parameters such as flow rate, pH and temperature
should be optimized for maximum product yield.
Both the organic and the bioproducts, have the same
products. At present the productivity of organic synthesis is
higher than enzymatic synthesis. Without the optimizing the
recirculation reactor the two can not be compared.
An interesting topic for future study would be on the
ability of the enzyme to oxidize several nitrogen sites on
one molecule. If this is possible the paramagnetic
properties would be further enhanced.
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